Tag Archives: march-in

Bazooka or Squirt Gun?: Working through 35 USC 200

Bayh-Dole gets at monopoly pricing through patent law, not licensing restrictions. Bayh-Dole is a part of federal patent law, not federal procurement regulations. This was a big change from the prior practice, including the Institutional Patent Agreement program. Unlike the … Continue reading

Posted in Bayh-Dole | Tagged , , , , , , | Comments Off on Bazooka or Squirt Gun?: Working through 35 USC 200

The March-In That Ain’t

I came across an interesting commentary by John Conley on the NIH’s refusal to exercise march-in rights under Bayh-Dole. The post is from January 2011 and has to do with the problems Genzyme has had producing an enzyme that helps … Continue reading

Posted in Bayh-Dole, Policy, Technology Transfer | Tagged , , | Comments Off on The March-In That Ain’t